Announcements Trials
Browse Landscape

Phase

Phase 1/2 4Phase 1 2Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 73NET 22Thoracic 10Gastrointestinal 10Lymphoid 5Sarcoma 4Dermatologic 4Other solid neoplasm 2Head & Neck 2Gynecologic 2CNS 2Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 1430Carcinoma, Renal Cell 587Urinary Bladder Neoplasms 369Kidney Neoplasms 257Carcinoma, Transitional Cell 193Neoplasm Metastasis 164Neoplasms 126Melanoma 83Breast Neoplasms 80Carcinoma, Non-Small-Cell Lung 78Testicular Neoplasms 67Ovarian Neoplasms 63Sarcoma 55Non-Muscle Invasive Bladder Neoplasms 52Urethral Neoplasms 51Wilms Tumor 49Lung Neoplasms 45Colorectal Neoplasms 45Uterine Cervical Neoplasms 40Neuroblastoma 39Pancreatic Neoplasms 38Penile Neoplasms 37Urologic Neoplasms 34Recurrence 32Lymphoma, Non-Hodgkin 32Ureteral Neoplasms 28Osteosarcoma 28Head and Neck Neoplasms 27Testicular Germ Cell Tumor 26Small Cell Lung Carcinoma 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Carcinoma, Neuroendocrine × Genitourinary × Clear all
NCT06683846 2025-08-24

Ivonescimab in the Treatment of Multiple Advanced Tumors

Fudan University

Phase 2 Recruiting
400 enrolled
CNSDermatologicEndocrineGenitourinarySarcoma

Urachal cancer, Carcinoma, Carcinoma, Basal Cell, Carcinoma, Transitional Cell, Kidney Neoplasms, Paget Disease, Extramammary, Paraganglioma, Penile Neoplasms, Pheochromocytoma, Prostatic Neoplasms, Rhabdomyosarcoma, Sarcoma, Angiomyolipoma, Carcinoma, Neuroendocrine, Perivascular Epithelioid Cell Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡